NCT06397131: An ongoing trial by Neurotech Pharmaceuticals
This trial is ongoing. It must report results 2 years from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06397131 |
|---|---|
| Title | A Multicenter Study to Determine the Safety and Efficacy of NT-501 Utilizing the Medica Membrane in Macular Telangiectasia Type 2 |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 6, 2025 |
| Completion date | April 27, 2026 |
| Required reporting date | April 27, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 4, 2025 |
| Days late | None |